Draft:Dr. Max Group: Difference between revisions

 

Line 67: Line 67:

{{Draft categories|

{{Draft categories|

[[:Category:Pharmacy companies of the Czech Republic]]

[[:Category:Health care companies of Europe]]

[[:Category:Companies established in 2004]]

[[:Category:Companies established in 2004]]

[[:Category:Retail companies of the Czech Republic]]

[[:Category:Retail companies of the Czech Republic]]

Pharmacy chain in Europe

Dr. Max Group is a European pharmacy and healthcare holding headquartered in Prague, Czech Republic. It is owned by the investment group Penta Investments and operates in the pharmaceutical, retail, wholesale, and manufacturing sectors.[1] The Group is led by Leonardo Ferrandino, who has served as Group CEO and President since 2016. [2]

It was founded in January 2009 and has branches in a total of 17 different European countries, mainly in Slovakia, Czech Republic, Poland, Romania, Serbia, and Italy [3], where it operates more than 3,000 pharmacies in total. As of 2025, the company was the second-largest pharmacy chain in Europe. [4]

While the Dr. Max pharmacy chain had been operating since 2009, the Dr. Max Group as a consolidated holding structure was created only later, in 2012, to integrate and oversee the network. [5]

Dr. Max was established officialy in 2004 by Penta Investments, following the acquisition of Česká lékárna holding. The company expanded to Slovakia and Poland in 2005, reaching 100 pharmacies by 2008.[6]

In 2011, it launched Dr. Max Pharma, a private label manufacturer. The brand began with nutritional supplements and expanded to over-the-counter products.[7]

Dr. Max acquired Lloyds Pharmacies and GEHE Pharma in 2012. This led to the creation of ViaPharma, a pharmaceutical distributor based in the Czech Republic.[8][9]

The company opened online pharmacy retail in 2014 with the launch of its e-commerce platform [3]. In 2025, the company opened a standalone store under the brand name BJUT, focused on the beauty segment, and launched a marketplace platform.[10]

Leave a Comment

Your email address will not be published. Required fields are marked *

Exit mobile version